We Can’t All Have It All: The Economic Limits of Pharmaceutical Innovation

• Autores: Rita Rubin
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 315, Nº. 18, 2016, págs. 1936-1937
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Sen Susan Collins (R, Me) praised a new proposed rule by the Department of Health and Human Services (HHS) that would increase the number of patients with opioid use disorders qualified physicians can treat with buprenorphine, a μ-opioid receptor partial agonist approved for clinical use by the Food and Drug Administration in 2002 (http://1.usa.gov/1XZUhq2).

    Qualified physicians are those who have received a waiver from the Substance Abuse and Mental Health Services Administration and the Drug Enforcement Agency to prescribe buprenorphine. In addition, they must possess subspecialty board certification in addiction medicine or addiction psychiatry or work in a qualified practice setting.